The global schizophrenia drugs market represents a critical segment of the pharmaceutical industry, addressing one of the most complex and chronic mental health disorders worldwide. Schizophrenia is a severe psychiatric condition characterized by symptoms such as hallucinations, delusions, disorganized thinking, and impaired cognitive functioning. The long-term nature of the disorder,...